PURESPRING THERAPEUTICS LIMITED
PURESPRING THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 12543677, incorporated on 1 April 2020. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 6 years. Registered office address: WC1B 3SR London, the United Kingdom. Formerly known as SYNCONA COLLABORATION (S) LIMITED. Directors include HASEEB AHMAD, MS MAINA BHAMAN, and DR MARCO BOORSMA, and 4 others. Sole shareholder is Syncona Limited. Associated with 19 related entities, including SYNCONA IP HOLDCO (2) LIMITED, BEACON THERAPEUTICS HOLDINGS LIMITED, and ELEVARA MEDICINES LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
SYNCONA COLLABORATION (S) LIMITED
Registered Address
8 BLOOMSBURY STREET
WC1B 3SR LONDON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (7)
| Date | Change | Details |
|---|---|---|
| 2026-04-17 | DIRECTOR ADDED | Dr John Tsai (director) |
| 2026-04-17 | DIRECTOR ADDED | Dr Marco Boorsma (director) |
| 2026-04-17 | DIRECTOR ADDED | Maina Bhaman (director) |
| 2026-04-17 | DIRECTOR ADDED | Haseeb Ahmad (director) |
| 2026-04-17 | DIRECTOR ADDED | Richard David Francis (director) |
| 2026-04-17 | DIRECTOR ADDED | Dr Sonia Hallen (director) |
| 2026-04-17 | DIRECTOR ADDED | Dr Christopher John Hollowood (director) |
Source Records (1)
| companieshouse | 12543677 | 2026-06-01 | open_in_new |